REGENXBIO Inc.
RGNX
$9.01
$0.9011.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,265.07% | 111.88% | 14.11% | -12.47% | 16.33% |
| Total Depreciation and Amortization | -1.26% | -1.69% | 1.57% | -2.22% | -3.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.49% | 84.93% | -56.95% | 20.61% | -36.91% |
| Change in Net Operating Assets | -54.07% | 40.79% | 92.07% | 250.37% | 50.52% |
| Cash from Operations | -246.72% | 206.34% | 22.01% | 10.88% | 17.96% |
| Capital Expenditure | 61.82% | 5.10% | -230.98% | 31.22% | 14.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -406.00% | 10.68% | -18.25% | 24,455.34% | -98.50% |
| Cash from Investing | -413.87% | 11.10% | -19.87% | 18,852.99% | -102.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -82.93% | 1,102.63% | -94.10% | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | -- | 100.00% | 93.74% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2,523.86% | 26.19% | 32.37% | -22.51% | 16.63% |
| Cash from Financing | 2,503.04% | 25.14% | 28.71% | -14.95% | -107.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -169.64% | 7,884.38% | 179.18% | 97.92% | -170.37% |